BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10586126)

  • 1. Etretinate therapy for papuloerythroderma.
    Fujii K; Kanno Y; Ohgo N
    Eur J Dermatol; 1999 Dec; 9(8):610-3. PubMed ID: 10586126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of papuloerythroderma of Ofuji with Re-PUVA: a case report and review of the therapy.
    Mutluer S; Yerebakan O; Alpsoy E; Ciftcioglu MA; Yilmaz E
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):480-3. PubMed ID: 15196168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofuji papuloerythroderma evolving to cutaneous T-cell lymphoma.
    Martínez-Barranca ML; Muñoz-Pérez MA; García-Morales I; Fernández-Crehuet JL; Segura J; Camacho F
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):104-6. PubMed ID: 15649203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Papuloerythroderma of Ofuji with urticarial lesions].
    Pullmann S; Luger T; Metze D
    J Dtsch Dermatol Ges; 2004 Jun; 2(6):443-7. PubMed ID: 16281602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term etretinate therapy for prurigo chronica multiformis.
    Fujii K; Kanno Y; Konishi K; Ohgou N
    J Dermatol; 2002 Mar; 29(3):146-51. PubMed ID: 11990249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Reiter's disease with severe skin manifestations successfully treated with oral etretinate].
    Umehara H; Kumagai S; Kashii S; Nagaoka K; Hoshino T; Imura H
    Ryumachi; 1990 Oct; 30(5):369-73, 374; discussion 373-4. PubMed ID: 2084859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsing coalescent papular dermatosis of elderly patients: a precursor or an abortive lesion of Ofuji papuloerythroderma.
    Fujii K; Kanno Y; Konishi K; Ohgou N
    Eur J Dermatol; 2003; 13(3):272-5. PubMed ID: 12804988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
    Kokelj F; Plozzer C; Torsello P; Trevisan G
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papuloerythroderma of Ofuji responding to treatment with cyclosporin.
    Sommer S; Henderson CA
    Clin Exp Dermatol; 2000 Jun; 25(4):293-5. PubMed ID: 10971488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of PUVA-induced keratoses to etretinate.
    Hudson-Peacock MJ; Angus B; Farr PM
    J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Keratoacanthoma centrifugum marginatum. Possible etiological role of papillomavirus and therapeutic response to etretinate].
    Lo Schiavo A; Pinto F; Degener AM; Bucci M; Ruocco V
    Ann Dermatol Venereol; 1996; 123(10):660-3. PubMed ID: 9615129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years.
    Abbott RA; Griffiths WA
    Clin Exp Dermatol; 2009 Apr; 34(3):378-9. PubMed ID: 19309372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papuloerythroderma of Ofuji: a report of 2 cases including the first European case associated with visceral carcinoma.
    Schepers C; Malvehy J; Azón-Masoliver A; Navarra E; Ferrando J; Mascaró JM
    Dermatology; 1996; 193(2):131-5. PubMed ID: 8884150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
    Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
    Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of milia en plaque successfully treated with oral etretinate.
    Ishiura N; Komine M; Kadono T; Kikuchi K; Tamaki K
    Br J Dermatol; 2007 Dec; 157(6):1287-9. PubMed ID: 17927794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perforant elastosis serpiginosa associated with Down's syndrome. Report of 2 cases].
    Vicente Villa MA; Rueda Muñoz A; González-Enseñat MA; Corretger Rauet J; Medina M; Palou Aymerich J
    An Esp Pediatr; 1998 Mar; 48(3):312-4. PubMed ID: 9608097
    [No Abstract]   [Full Text] [Related]  

  • 18. Papuloerythroderma of Ofuji: a report of three cases and review of the literature.
    Tay YK; Tan KC; Wong WK; Ong BH
    Br J Dermatol; 1994 Jun; 130(6):773-6. PubMed ID: 8011505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papuloerythroderma and cutaneous T cell lymphoma.
    Dwyer CM; Chapman RS; Smith GD
    Dermatology; 1994; 188(4):326-8. PubMed ID: 8193409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of internal malignancy in papuloerythroderma of Ofuji: a case series from Japan.
    Teraki Y; Aso Y; Sato Y
    Dermatology; 2012; 224(1):5-9. PubMed ID: 22327542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.